Global Transdermal Drug Delivery System Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 113

Published Date: 18 Mar 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.

According to our (Global Info Research) latest study, the global Transdermal Drug Delivery System market size was valued at USD 15500 million in 2022 and is forecast to a readjusted size of USD 35850 million by 2029 with a CAGR of 12.7% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Transdermal Drug Delivery System key players include Hisamitsu, Mylan, GSK, Novartis, Teve (Actavis), etc. Global top five manufacturers hold a share over 65%. North America is the largest market, with a share over 40%, followed by Europe and Asia-Pacific, both have a share over 45% percent.

In terms of product, Nitroglycerin is the largest segment, with a share over 25%. And in terms of application, the largest application is OTC, followed by RX.

This report is a detailed and comprehensive analysis for global Transdermal Drug Delivery System market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Transdermal Drug Delivery System market size and forecasts, in consumption value ($ Million), 2018-2029
Global Transdermal Drug Delivery System market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Transdermal Drug Delivery System market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Transdermal Drug Delivery System market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Transdermal Drug Delivery System
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Transdermal Drug Delivery System market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hisamitsu, Mylan, GSK, Novartis and Teve (Actavis), etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Transdermal Drug Delivery System market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Fentanyl
    Nitroglycerin
    Estradiol
    Nicotine
    Other

Market segment by Application
    OTC
    Rx

Market segment by players, this report covers
    Hisamitsu
    Mylan
    GSK
    Novartis
    Teve (Actavis)
    Johnson & Johnson
    Lohmann
    Teikoku Seiyaku
    Bayer
    Lingrui
    Sanofi
    Qizheng
    Endo
    Huarun 999
    Haw Par
    Nichiban
    Mentholatum
    Laboratoires Genevrier

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Transdermal Drug Delivery System product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Transdermal Drug Delivery System, with revenue, gross margin and global market share of Transdermal Drug Delivery System from 2018 to 2023.
Chapter 3, the Transdermal Drug Delivery System competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Transdermal Drug Delivery System market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Transdermal Drug Delivery System.
Chapter 13, to describe Transdermal Drug Delivery System research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Transdermal Drug Delivery System
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Transdermal Drug Delivery System by Type
        1.3.1 Overview: Global Transdermal Drug Delivery System Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Transdermal Drug Delivery System Consumption Value Market Share by Type in 2022
        1.3.3 Fentanyl
        1.3.4 Nitroglycerin
        1.3.5 Estradiol
        1.3.6 Nicotine
        1.3.7 Other
    1.4 Global Transdermal Drug Delivery System Market by Application
        1.4.1 Overview: Global Transdermal Drug Delivery System Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 OTC
        1.4.3 Rx
    1.5 Global Transdermal Drug Delivery System Market Size & Forecast
    1.6 Global Transdermal Drug Delivery System Market Size and Forecast by Region
        1.6.1 Global Transdermal Drug Delivery System Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Transdermal Drug Delivery System Market Size by Region, (2018-2029)
        1.6.3 North America Transdermal Drug Delivery System Market Size and Prospect (2018-2029)
        1.6.4 Europe Transdermal Drug Delivery System Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Transdermal Drug Delivery System Market Size and Prospect (2018-2029)
        1.6.6 South America Transdermal Drug Delivery System Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Transdermal Drug Delivery System Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Hisamitsu
        2.1.1 Hisamitsu Details
        2.1.2 Hisamitsu Major Business
        2.1.3 Hisamitsu Transdermal Drug Delivery System Product and Solutions
        2.1.4 Hisamitsu Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Hisamitsu Recent Developments and Future Plans
    2.2 Mylan
        2.2.1 Mylan Details
        2.2.2 Mylan Major Business
        2.2.3 Mylan Transdermal Drug Delivery System Product and Solutions
        2.2.4 Mylan Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Mylan Recent Developments and Future Plans
    2.3 GSK
        2.3.1 GSK Details
        2.3.2 GSK Major Business
        2.3.3 GSK Transdermal Drug Delivery System Product and Solutions
        2.3.4 GSK Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 GSK Recent Developments and Future Plans
    2.4 Novartis
        2.4.1 Novartis Details
        2.4.2 Novartis Major Business
        2.4.3 Novartis Transdermal Drug Delivery System Product and Solutions
        2.4.4 Novartis Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Novartis Recent Developments and Future Plans
    2.5 Teve (Actavis)
        2.5.1 Teve (Actavis) Details
        2.5.2 Teve (Actavis) Major Business
        2.5.3 Teve (Actavis) Transdermal Drug Delivery System Product and Solutions
        2.5.4 Teve (Actavis) Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Teve (Actavis) Recent Developments and Future Plans
    2.6 Johnson & Johnson
        2.6.1 Johnson & Johnson Details
        2.6.2 Johnson & Johnson Major Business
        2.6.3 Johnson & Johnson Transdermal Drug Delivery System Product and Solutions
        2.6.4 Johnson & Johnson Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Johnson & Johnson Recent Developments and Future Plans
    2.7 Lohmann
        2.7.1 Lohmann Details
        2.7.2 Lohmann Major Business
        2.7.3 Lohmann Transdermal Drug Delivery System Product and Solutions
        2.7.4 Lohmann Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Lohmann Recent Developments and Future Plans
    2.8 Teikoku Seiyaku
        2.8.1 Teikoku Seiyaku Details
        2.8.2 Teikoku Seiyaku Major Business
        2.8.3 Teikoku Seiyaku Transdermal Drug Delivery System Product and Solutions
        2.8.4 Teikoku Seiyaku Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Teikoku Seiyaku Recent Developments and Future Plans
    2.9 Bayer
        2.9.1 Bayer Details
        2.9.2 Bayer Major Business
        2.9.3 Bayer Transdermal Drug Delivery System Product and Solutions
        2.9.4 Bayer Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Bayer Recent Developments and Future Plans
    2.10 Lingrui
        2.10.1 Lingrui Details
        2.10.2 Lingrui Major Business
        2.10.3 Lingrui Transdermal Drug Delivery System Product and Solutions
        2.10.4 Lingrui Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Lingrui Recent Developments and Future Plans
    2.11 Sanofi
        2.11.1 Sanofi Details
        2.11.2 Sanofi Major Business
        2.11.3 Sanofi Transdermal Drug Delivery System Product and Solutions
        2.11.4 Sanofi Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Sanofi Recent Developments and Future Plans
    2.12 Qizheng
        2.12.1 Qizheng Details
        2.12.2 Qizheng Major Business
        2.12.3 Qizheng Transdermal Drug Delivery System Product and Solutions
        2.12.4 Qizheng Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Qizheng Recent Developments and Future Plans
    2.13 Endo
        2.13.1 Endo Details
        2.13.2 Endo Major Business
        2.13.3 Endo Transdermal Drug Delivery System Product and Solutions
        2.13.4 Endo Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Endo Recent Developments and Future Plans
    2.14 Huarun 999
        2.14.1 Huarun 999 Details
        2.14.2 Huarun 999 Major Business
        2.14.3 Huarun 999 Transdermal Drug Delivery System Product and Solutions
        2.14.4 Huarun 999 Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Huarun 999 Recent Developments and Future Plans
    2.15 Haw Par
        2.15.1 Haw Par Details
        2.15.2 Haw Par Major Business
        2.15.3 Haw Par Transdermal Drug Delivery System Product and Solutions
        2.15.4 Haw Par Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 Haw Par Recent Developments and Future Plans
    2.16 Nichiban
        2.16.1 Nichiban Details
        2.16.2 Nichiban Major Business
        2.16.3 Nichiban Transdermal Drug Delivery System Product and Solutions
        2.16.4 Nichiban Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
        2.16.5 Nichiban Recent Developments and Future Plans
    2.17 Mentholatum
        2.17.1 Mentholatum Details
        2.17.2 Mentholatum Major Business
        2.17.3 Mentholatum Transdermal Drug Delivery System Product and Solutions
        2.17.4 Mentholatum Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
        2.17.5 Mentholatum Recent Developments and Future Plans
    2.18 Laboratoires Genevrier
        2.18.1 Laboratoires Genevrier Details
        2.18.2 Laboratoires Genevrier Major Business
        2.18.3 Laboratoires Genevrier Transdermal Drug Delivery System Product and Solutions
        2.18.4 Laboratoires Genevrier Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
        2.18.5 Laboratoires Genevrier Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Transdermal Drug Delivery System Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Transdermal Drug Delivery System by Company Revenue
        3.2.2 Top 3 Transdermal Drug Delivery System Players Market Share in 2022
        3.2.3 Top 6 Transdermal Drug Delivery System Players Market Share in 2022
    3.3 Transdermal Drug Delivery System Market: Overall Company Footprint Analysis
        3.3.1 Transdermal Drug Delivery System Market: Region Footprint
        3.3.2 Transdermal Drug Delivery System Market: Company Product Type Footprint
        3.3.3 Transdermal Drug Delivery System Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Transdermal Drug Delivery System Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Transdermal Drug Delivery System Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Transdermal Drug Delivery System Consumption Value Market Share by Application (2018-2023)
    5.2 Global Transdermal Drug Delivery System Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Transdermal Drug Delivery System Consumption Value by Type (2018-2029)
    6.2 North America Transdermal Drug Delivery System Consumption Value by Application (2018-2029)
    6.3 North America Transdermal Drug Delivery System Market Size by Country
        6.3.1 North America Transdermal Drug Delivery System Consumption Value by Country (2018-2029)
        6.3.2 United States Transdermal Drug Delivery System Market Size and Forecast (2018-2029)
        6.3.3 Canada Transdermal Drug Delivery System Market Size and Forecast (2018-2029)
        6.3.4 Mexico Transdermal Drug Delivery System Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Transdermal Drug Delivery System Consumption Value by Type (2018-2029)
    7.2 Europe Transdermal Drug Delivery System Consumption Value by Application (2018-2029)
    7.3 Europe Transdermal Drug Delivery System Market Size by Country
        7.3.1 Europe Transdermal Drug Delivery System Consumption Value by Country (2018-2029)
        7.3.2 Germany Transdermal Drug Delivery System Market Size and Forecast (2018-2029)
        7.3.3 France Transdermal Drug Delivery System Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Transdermal Drug Delivery System Market Size and Forecast (2018-2029)
        7.3.5 Russia Transdermal Drug Delivery System Market Size and Forecast (2018-2029)
        7.3.6 Italy Transdermal Drug Delivery System Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Transdermal Drug Delivery System Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Transdermal Drug Delivery System Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Transdermal Drug Delivery System Market Size by Region
        8.3.1 Asia-Pacific Transdermal Drug Delivery System Consumption Value by Region (2018-2029)
        8.3.2 China Transdermal Drug Delivery System Market Size and Forecast (2018-2029)
        8.3.3 Japan Transdermal Drug Delivery System Market Size and Forecast (2018-2029)
        8.3.4 South Korea Transdermal Drug Delivery System Market Size and Forecast (2018-2029)
        8.3.5 India Transdermal Drug Delivery System Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Transdermal Drug Delivery System Market Size and Forecast (2018-2029)
        8.3.7 Australia Transdermal Drug Delivery System Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Transdermal Drug Delivery System Consumption Value by Type (2018-2029)
    9.2 South America Transdermal Drug Delivery System Consumption Value by Application (2018-2029)
    9.3 South America Transdermal Drug Delivery System Market Size by Country
        9.3.1 South America Transdermal Drug Delivery System Consumption Value by Country (2018-2029)
        9.3.2 Brazil Transdermal Drug Delivery System Market Size and Forecast (2018-2029)
        9.3.3 Argentina Transdermal Drug Delivery System Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Transdermal Drug Delivery System Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Transdermal Drug Delivery System Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Transdermal Drug Delivery System Market Size by Country
        10.3.1 Middle East & Africa Transdermal Drug Delivery System Consumption Value by Country (2018-2029)
        10.3.2 Turkey Transdermal Drug Delivery System Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Transdermal Drug Delivery System Market Size and Forecast (2018-2029)
        10.3.4 UAE Transdermal Drug Delivery System Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Transdermal Drug Delivery System Market Drivers
    11.2 Transdermal Drug Delivery System Market Restraints
    11.3 Transdermal Drug Delivery System Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Transdermal Drug Delivery System Industry Chain
    12.2 Transdermal Drug Delivery System Upstream Analysis
    12.3 Transdermal Drug Delivery System Midstream Analysis
    12.4 Transdermal Drug Delivery System Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Transdermal Drug Delivery System Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Transdermal Drug Delivery System Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Transdermal Drug Delivery System Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Transdermal Drug Delivery System Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Hisamitsu Company Information, Head Office, and Major Competitors
    Table 6. Hisamitsu Major Business
    Table 7. Hisamitsu Transdermal Drug Delivery System Product and Solutions
    Table 8. Hisamitsu Transdermal Drug Delivery System Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Hisamitsu Recent Developments and Future Plans
    Table 10. Mylan Company Information, Head Office, and Major Competitors
    Table 11. Mylan Major Business
    Table 12. Mylan Transdermal Drug Delivery System Product and Solutions
    Table 13. Mylan Transdermal Drug Delivery System Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Mylan Recent Developments and Future Plans
    Table 15. GSK Company Information, Head Office, and Major Competitors
    Table 16. GSK Major Business
    Table 17. GSK Transdermal Drug Delivery System Product and Solutions
    Table 18. GSK Transdermal Drug Delivery System Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. GSK Recent Developments and Future Plans
    Table 20. Novartis Company Information, Head Office, and Major Competitors
    Table 21. Novartis Major Business
    Table 22. Novartis Transdermal Drug Delivery System Product and Solutions
    Table 23. Novartis Transdermal Drug Delivery System Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Novartis Recent Developments and Future Plans
    Table 25. Teve (Actavis) Company Information, Head Office, and Major Competitors
    Table 26. Teve (Actavis) Major Business
    Table 27. Teve (Actavis) Transdermal Drug Delivery System Product and Solutions
    Table 28. Teve (Actavis) Transdermal Drug Delivery System Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Teve (Actavis) Recent Developments and Future Plans
    Table 30. Johnson & Johnson Company Information, Head Office, and Major Competitors
    Table 31. Johnson & Johnson Major Business
    Table 32. Johnson & Johnson Transdermal Drug Delivery System Product and Solutions
    Table 33. Johnson & Johnson Transdermal Drug Delivery System Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Johnson & Johnson Recent Developments and Future Plans
    Table 35. Lohmann Company Information, Head Office, and Major Competitors
    Table 36. Lohmann Major Business
    Table 37. Lohmann Transdermal Drug Delivery System Product and Solutions
    Table 38. Lohmann Transdermal Drug Delivery System Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Lohmann Recent Developments and Future Plans
    Table 40. Teikoku Seiyaku Company Information, Head Office, and Major Competitors
    Table 41. Teikoku Seiyaku Major Business
    Table 42. Teikoku Seiyaku Transdermal Drug Delivery System Product and Solutions
    Table 43. Teikoku Seiyaku Transdermal Drug Delivery System Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Teikoku Seiyaku Recent Developments and Future Plans
    Table 45. Bayer Company Information, Head Office, and Major Competitors
    Table 46. Bayer Major Business
    Table 47. Bayer Transdermal Drug Delivery System Product and Solutions
    Table 48. Bayer Transdermal Drug Delivery System Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Bayer Recent Developments and Future Plans
    Table 50. Lingrui Company Information, Head Office, and Major Competitors
    Table 51. Lingrui Major Business
    Table 52. Lingrui Transdermal Drug Delivery System Product and Solutions
    Table 53. Lingrui Transdermal Drug Delivery System Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Lingrui Recent Developments and Future Plans
    Table 55. Sanofi Company Information, Head Office, and Major Competitors
    Table 56. Sanofi Major Business
    Table 57. Sanofi Transdermal Drug Delivery System Product and Solutions
    Table 58. Sanofi Transdermal Drug Delivery System Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. Sanofi Recent Developments and Future Plans
    Table 60. Qizheng Company Information, Head Office, and Major Competitors
    Table 61. Qizheng Major Business
    Table 62. Qizheng Transdermal Drug Delivery System Product and Solutions
    Table 63. Qizheng Transdermal Drug Delivery System Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 64. Qizheng Recent Developments and Future Plans
    Table 65. Endo Company Information, Head Office, and Major Competitors
    Table 66. Endo Major Business
    Table 67. Endo Transdermal Drug Delivery System Product and Solutions
    Table 68. Endo Transdermal Drug Delivery System Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 69. Endo Recent Developments and Future Plans
    Table 70. Huarun 999 Company Information, Head Office, and Major Competitors
    Table 71. Huarun 999 Major Business
    Table 72. Huarun 999 Transdermal Drug Delivery System Product and Solutions
    Table 73. Huarun 999 Transdermal Drug Delivery System Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 74. Huarun 999 Recent Developments and Future Plans
    Table 75. Haw Par Company Information, Head Office, and Major Competitors
    Table 76. Haw Par Major Business
    Table 77. Haw Par Transdermal Drug Delivery System Product and Solutions
    Table 78. Haw Par Transdermal Drug Delivery System Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 79. Haw Par Recent Developments and Future Plans
    Table 80. Nichiban Company Information, Head Office, and Major Competitors
    Table 81. Nichiban Major Business
    Table 82. Nichiban Transdermal Drug Delivery System Product and Solutions
    Table 83. Nichiban Transdermal Drug Delivery System Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 84. Nichiban Recent Developments and Future Plans
    Table 85. Mentholatum Company Information, Head Office, and Major Competitors
    Table 86. Mentholatum Major Business
    Table 87. Mentholatum Transdermal Drug Delivery System Product and Solutions
    Table 88. Mentholatum Transdermal Drug Delivery System Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Mentholatum Recent Developments and Future Plans
    Table 90. Laboratoires Genevrier Company Information, Head Office, and Major Competitors
    Table 91. Laboratoires Genevrier Major Business
    Table 92. Laboratoires Genevrier Transdermal Drug Delivery System Product and Solutions
    Table 93. Laboratoires Genevrier Transdermal Drug Delivery System Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 94. Laboratoires Genevrier Recent Developments and Future Plans
    Table 95. Global Transdermal Drug Delivery System Revenue (USD Million) by Players (2018-2023)
    Table 96. Global Transdermal Drug Delivery System Revenue Share by Players (2018-2023)
    Table 97. Breakdown of Transdermal Drug Delivery System by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 98. Market Position of Players in Transdermal Drug Delivery System, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 99. Head Office of Key Transdermal Drug Delivery System Players
    Table 100. Transdermal Drug Delivery System Market: Company Product Type Footprint
    Table 101. Transdermal Drug Delivery System Market: Company Product Application Footprint
    Table 102. Transdermal Drug Delivery System New Market Entrants and Barriers to Market Entry
    Table 103. Transdermal Drug Delivery System Mergers, Acquisition, Agreements, and Collaborations
    Table 104. Global Transdermal Drug Delivery System Consumption Value (USD Million) by Type (2018-2023)
    Table 105. Global Transdermal Drug Delivery System Consumption Value Share by Type (2018-2023)
    Table 106. Global Transdermal Drug Delivery System Consumption Value Forecast by Type (2024-2029)
    Table 107. Global Transdermal Drug Delivery System Consumption Value by Application (2018-2023)
    Table 108. Global Transdermal Drug Delivery System Consumption Value Forecast by Application (2024-2029)
    Table 109. North America Transdermal Drug Delivery System Consumption Value by Type (2018-2023) & (USD Million)
    Table 110. North America Transdermal Drug Delivery System Consumption Value by Type (2024-2029) & (USD Million)
    Table 111. North America Transdermal Drug Delivery System Consumption Value by Application (2018-2023) & (USD Million)
    Table 112. North America Transdermal Drug Delivery System Consumption Value by Application (2024-2029) & (USD Million)
    Table 113. North America Transdermal Drug Delivery System Consumption Value by Country (2018-2023) & (USD Million)
    Table 114. North America Transdermal Drug Delivery System Consumption Value by Country (2024-2029) & (USD Million)
    Table 115. Europe Transdermal Drug Delivery System Consumption Value by Type (2018-2023) & (USD Million)
    Table 116. Europe Transdermal Drug Delivery System Consumption Value by Type (2024-2029) & (USD Million)
    Table 117. Europe Transdermal Drug Delivery System Consumption Value by Application (2018-2023) & (USD Million)
    Table 118. Europe Transdermal Drug Delivery System Consumption Value by Application (2024-2029) & (USD Million)
    Table 119. Europe Transdermal Drug Delivery System Consumption Value by Country (2018-2023) & (USD Million)
    Table 120. Europe Transdermal Drug Delivery System Consumption Value by Country (2024-2029) & (USD Million)
    Table 121. Asia-Pacific Transdermal Drug Delivery System Consumption Value by Type (2018-2023) & (USD Million)
    Table 122. Asia-Pacific Transdermal Drug Delivery System Consumption Value by Type (2024-2029) & (USD Million)
    Table 123. Asia-Pacific Transdermal Drug Delivery System Consumption Value by Application (2018-2023) & (USD Million)
    Table 124. Asia-Pacific Transdermal Drug Delivery System Consumption Value by Application (2024-2029) & (USD Million)
    Table 125. Asia-Pacific Transdermal Drug Delivery System Consumption Value by Region (2018-2023) & (USD Million)
    Table 126. Asia-Pacific Transdermal Drug Delivery System Consumption Value by Region (2024-2029) & (USD Million)
    Table 127. South America Transdermal Drug Delivery System Consumption Value by Type (2018-2023) & (USD Million)
    Table 128. South America Transdermal Drug Delivery System Consumption Value by Type (2024-2029) & (USD Million)
    Table 129. South America Transdermal Drug Delivery System Consumption Value by Application (2018-2023) & (USD Million)
    Table 130. South America Transdermal Drug Delivery System Consumption Value by Application (2024-2029) & (USD Million)
    Table 131. South America Transdermal Drug Delivery System Consumption Value by Country (2018-2023) & (USD Million)
    Table 132. South America Transdermal Drug Delivery System Consumption Value by Country (2024-2029) & (USD Million)
    Table 133. Middle East & Africa Transdermal Drug Delivery System Consumption Value by Type (2018-2023) & (USD Million)
    Table 134. Middle East & Africa Transdermal Drug Delivery System Consumption Value by Type (2024-2029) & (USD Million)
    Table 135. Middle East & Africa Transdermal Drug Delivery System Consumption Value by Application (2018-2023) & (USD Million)
    Table 136. Middle East & Africa Transdermal Drug Delivery System Consumption Value by Application (2024-2029) & (USD Million)
    Table 137. Middle East & Africa Transdermal Drug Delivery System Consumption Value by Country (2018-2023) & (USD Million)
    Table 138. Middle East & Africa Transdermal Drug Delivery System Consumption Value by Country (2024-2029) & (USD Million)
    Table 139. Transdermal Drug Delivery System Raw Material
    Table 140. Key Suppliers of Transdermal Drug Delivery System Raw Materials
List of Figures
    Figure 1. Transdermal Drug Delivery System Picture
    Figure 2. Global Transdermal Drug Delivery System Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Transdermal Drug Delivery System Consumption Value Market Share by Type in 2022
    Figure 4. Fentanyl
    Figure 5. Nitroglycerin
    Figure 6. Estradiol
    Figure 7. Nicotine
    Figure 8. Other
    Figure 9. Global Transdermal Drug Delivery System Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 10. Transdermal Drug Delivery System Consumption Value Market Share by Application in 2022
    Figure 11. OTC Picture
    Figure 12. Rx Picture
    Figure 13. Global Transdermal Drug Delivery System Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 14. Global Transdermal Drug Delivery System Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 15. Global Market Transdermal Drug Delivery System Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 16. Global Transdermal Drug Delivery System Consumption Value Market Share by Region (2018-2029)
    Figure 17. Global Transdermal Drug Delivery System Consumption Value Market Share by Region in 2022
    Figure 18. North America Transdermal Drug Delivery System Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Transdermal Drug Delivery System Consumption Value (2018-2029) & (USD Million)
    Figure 20. Asia-Pacific Transdermal Drug Delivery System Consumption Value (2018-2029) & (USD Million)
    Figure 21. South America Transdermal Drug Delivery System Consumption Value (2018-2029) & (USD Million)
    Figure 22. Middle East and Africa Transdermal Drug Delivery System Consumption Value (2018-2029) & (USD Million)
    Figure 23. Global Transdermal Drug Delivery System Revenue Share by Players in 2022
    Figure 24. Transdermal Drug Delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 25. Global Top 3 Players Transdermal Drug Delivery System Market Share in 2022
    Figure 26. Global Top 6 Players Transdermal Drug Delivery System Market Share in 2022
    Figure 27. Global Transdermal Drug Delivery System Consumption Value Share by Type (2018-2023)
    Figure 28. Global Transdermal Drug Delivery System Market Share Forecast by Type (2024-2029)
    Figure 29. Global Transdermal Drug Delivery System Consumption Value Share by Application (2018-2023)
    Figure 30. Global Transdermal Drug Delivery System Market Share Forecast by Application (2024-2029)
    Figure 31. North America Transdermal Drug Delivery System Consumption Value Market Share by Type (2018-2029)
    Figure 32. North America Transdermal Drug Delivery System Consumption Value Market Share by Application (2018-2029)
    Figure 33. North America Transdermal Drug Delivery System Consumption Value Market Share by Country (2018-2029)
    Figure 34. United States Transdermal Drug Delivery System Consumption Value (2018-2029) & (USD Million)
    Figure 35. Canada Transdermal Drug Delivery System Consumption Value (2018-2029) & (USD Million)
    Figure 36. Mexico Transdermal Drug Delivery System Consumption Value (2018-2029) & (USD Million)
    Figure 37. Europe Transdermal Drug Delivery System Consumption Value Market Share by Type (2018-2029)
    Figure 38. Europe Transdermal Drug Delivery System Consumption Value Market Share by Application (2018-2029)
    Figure 39. Europe Transdermal Drug Delivery System Consumption Value Market Share by Country (2018-2029)
    Figure 40. Germany Transdermal Drug Delivery System Consumption Value (2018-2029) & (USD Million)
    Figure 41. France Transdermal Drug Delivery System Consumption Value (2018-2029) & (USD Million)
    Figure 42. United Kingdom Transdermal Drug Delivery System Consumption Value (2018-2029) & (USD Million)
    Figure 43. Russia Transdermal Drug Delivery System Consumption Value (2018-2029) & (USD Million)
    Figure 44. Italy Transdermal Drug Delivery System Consumption Value (2018-2029) & (USD Million)
    Figure 45. Asia-Pacific Transdermal Drug Delivery System Consumption Value Market Share by Type (2018-2029)
    Figure 46. Asia-Pacific Transdermal Drug Delivery System Consumption Value Market Share by Application (2018-2029)
    Figure 47. Asia-Pacific Transdermal Drug Delivery System Consumption Value Market Share by Region (2018-2029)
    Figure 48. China Transdermal Drug Delivery System Consumption Value (2018-2029) & (USD Million)
    Figure 49. Japan Transdermal Drug Delivery System Consumption Value (2018-2029) & (USD Million)
    Figure 50. South Korea Transdermal Drug Delivery System Consumption Value (2018-2029) & (USD Million)
    Figure 51. India Transdermal Drug Delivery System Consumption Value (2018-2029) & (USD Million)
    Figure 52. Southeast Asia Transdermal Drug Delivery System Consumption Value (2018-2029) & (USD Million)
    Figure 53. Australia Transdermal Drug Delivery System Consumption Value (2018-2029) & (USD Million)
    Figure 54. South America Transdermal Drug Delivery System Consumption Value Market Share by Type (2018-2029)
    Figure 55. South America Transdermal Drug Delivery System Consumption Value Market Share by Application (2018-2029)
    Figure 56. South America Transdermal Drug Delivery System Consumption Value Market Share by Country (2018-2029)
    Figure 57. Brazil Transdermal Drug Delivery System Consumption Value (2018-2029) & (USD Million)
    Figure 58. Argentina Transdermal Drug Delivery System Consumption Value (2018-2029) & (USD Million)
    Figure 59. Middle East and Africa Transdermal Drug Delivery System Consumption Value Market Share by Type (2018-2029)
    Figure 60. Middle East and Africa Transdermal Drug Delivery System Consumption Value Market Share by Application (2018-2029)
    Figure 61. Middle East and Africa Transdermal Drug Delivery System Consumption Value Market Share by Country (2018-2029)
    Figure 62. Turkey Transdermal Drug Delivery System Consumption Value (2018-2029) & (USD Million)
    Figure 63. Saudi Arabia Transdermal Drug Delivery System Consumption Value (2018-2029) & (USD Million)
    Figure 64. UAE Transdermal Drug Delivery System Consumption Value (2018-2029) & (USD Million)
    Figure 65. Transdermal Drug Delivery System Market Drivers
    Figure 66. Transdermal Drug Delivery System Market Restraints
    Figure 67. Transdermal Drug Delivery System Market Trends
    Figure 68. Porters Five Forces Analysis
    Figure 69. Manufacturing Cost Structure Analysis of Transdermal Drug Delivery System in 2022
    Figure 70. Manufacturing Process Analysis of Transdermal Drug Delivery System
    Figure 71. Transdermal Drug Delivery System Industrial Chain
    Figure 72. Methodology
    Figure 73. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Transdermal Drug Delivery System Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Transdermal Drug Delivery System Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Transdermal Drug Delivery System market size was valued at USD 15500 million in 2023 and is forecast to a readjusted size of USD 35850 million by 2030 with a CAGR of 12.7% during review period.

Global Transdermal Drug Delivery System Supply, Demand and Key Producers, 2024-2030

Global Transdermal Drug Delivery System Supply, Demand and Key Producers, 2024-2030

date 10 Feb 2024

date Medical Care

The global Transdermal Drug Delivery System market size is expected to reach $ 35850 million by 2030, rising at a market growth of 12.7% CAGR during the forecast period (2024-2030).

Product Tags

Transdermal Drug Delivery System

Microneedle Transdermal Drug Delivery System

Medical Transdermal Drug Delivery System

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>